# Five9, Inc.: financial statements, quarterly

FIVN · Nasdaq · CIK 1288847 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fivn.md) · [Financials](/companies/fivn/financials.md) · [Filings](/companies/fivn/filings.md) · [Insiders](/companies/fivn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fivn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [230](/filings/0001288847-25-000028.md) | [239](/filings/0001288847-25-000028.md) | [247](/filings/0001288847-26-000023.md) | [252](/filings/0001288847-26-000023.md) | [264](/filings/0001288847-26-000023.md) | [279](/filings/0001288847-26-000023.md) | [280](/filings/0001288847-26-000079.md) | [283](/filings/0001288847-26-000123.md) | [286](/filings/0001288847-26-000023.md) | [300](/filings/0001288847-26-000023.md) | [305](/filings/0001288847-26-000079.md) | [312](/filings/0001288847-26-000123.md) |
| Cost of revenue | $m | [111](/filings/0001288847-25-000028.md) | [112](/filings/0001288847-25-000028.md) | [115](/filings/0001288847-26-000023.md) | [118](/filings/0001288847-26-000023.md) | [122](/filings/0001288847-26-000023.md) | [123](/filings/0001288847-26-000023.md) | [126](/filings/0001288847-26-000079.md) | [128](/filings/0001288847-26-000123.md) | [129](/filings/0001288847-26-000023.md) | [134](/filings/0001288847-26-000023.md) | [135](/filings/0001288847-26-000079.md) | [146](/filings/0001288847-26-000123.md) |
| Gross profit | $m | [119](/filings/0001288847-25-000028.md) | [127](/filings/0001288847-25-000028.md) | [132](/filings/0001288847-26-000023.md) | [134](/filings/0001288847-26-000023.md) | [142](/filings/0001288847-26-000023.md) | [156](/filings/0001288847-26-000023.md) | [154](/filings/0001288847-26-000079.md) | [155](/filings/0001288847-26-000123.md) | [157](/filings/0001288847-26-000023.md) | [166](/filings/0001288847-26-000023.md) | [171](/filings/0001288847-26-000079.md) | [167](/filings/0001288847-26-000123.md) |
| Research and development | $m | [40.4](/filings/0001288847-25-000028.md) | [38.9](/filings/0001288847-25-000028.md) | [41.5](/filings/0001288847-26-000023.md) | [40.7](/filings/0001288847-26-000023.md) | [42.5](/filings/0001288847-26-000023.md) | [41.5](/filings/0001288847-26-000023.md) | [41.1](/filings/0001288847-26-000079.md) | [39.9](/filings/0001288847-26-000123.md) | [35.2](/filings/0001288847-26-000023.md) | [36.1](/filings/0001288847-26-000023.md) | [39.7](/filings/0001288847-26-000079.md) | [42.1](/filings/0001288847-26-000123.md) |
| Operating income | $m | [(25.7)](/filings/0001288847-25-000028.md) | [(18.6)](/filings/0001288847-25-000028.md) | [(20.7)](/filings/0001288847-26-000023.md) | [(19.4)](/filings/0001288847-26-000023.md) | [(15.4)](/filings/0001288847-26-000023.md) | [4.2](/filings/0001288847-26-000023.md) | [(5.4)](/filings/0001288847-26-000079.md) | [(1.6)](/filings/0001288847-26-000123.md) | [16.0](/filings/0001288847-26-000023.md) | [19.8](/filings/0001288847-26-000023.md) | [18.5](/filings/0001288847-26-000079.md) | [2.0](/filings/0001288847-26-000123.md) |
| Interest expense | $m | [2.0](/filings/0001288847-24-000012.md) | [2.0](/filings/0001288847-24-000012.md) | [2.6](/filings/0001288847-24-000061.md) | [3.9](/filings/0001288847-26-000023.md) | [4.1](/filings/0001288847-26-000023.md) | [4.3](/filings/0001288847-26-000023.md) | [4.1](/filings/0001288847-26-000079.md) | [3.8](/filings/0001288847-26-000123.md) | [3.1](/filings/0001288847-26-000023.md) | [3.1](/filings/0001288847-26-000023.md) | [3.1](/filings/0001288847-26-000079.md) | [3.5](/filings/0001288847-26-000123.md) |
| Income tax | $m | [0.9](/filings/0001288847-25-000028.md) | [0.1](/filings/0001288847-25-000028.md) | [1.0](/filings/0001288847-26-000023.md) | [3.3](/filings/0001288847-26-000023.md) | [(3.9)](/filings/0001288847-26-000023.md) | [(0.4)](/filings/0001288847-26-000023.md) | [0.2](/filings/0001288847-26-000079.md) | [1.4](/filings/0001288847-26-000123.md) | [0.6](/filings/0001288847-26-000023.md) | [3.3](/filings/0001288847-26-000023.md) | [2.2](/filings/0001288847-26-000079.md) | [0.9](/filings/0001288847-26-000123.md) |
| Net income | $m | [(20.4)](/filings/0001288847-25-000028.md) | [(12.4)](/filings/0001288847-25-000028.md) | [(7.1)](/filings/0001288847-26-000023.md) | [(12.8)](/filings/0001288847-26-000023.md) | [(4.5)](/filings/0001288847-26-000023.md) | [11.6](/filings/0001288847-26-000023.md) | [0.6](/filings/0001288847-26-000079.md) | [1.2](/filings/0001288847-26-000123.md) | [18.0](/filings/0001288847-26-000023.md) | [19.7](/filings/0001288847-26-000023.md) | [18.4](/filings/0001288847-26-000079.md) | [3.4](/filings/0001288847-26-000123.md) |
| Diluted EPS | $ per share | [(0.28)](/filings/0001288847-25-000028.md) | [(0.17)](/filings/0001288847-25-000028.md) | [(0.10)](/filings/0001288847-26-000023.md) | [(0.17)](/filings/0001288847-26-000023.md) | [(0.06)](/filings/0001288847-26-000023.md) | [0.13](/filings/0001288847-26-000023.md) | [0.01](/filings/0001288847-26-000079.md) | [0.01](/filings/0001288847-26-000123.md) | [0.21](/filings/0001288847-26-000023.md) | [0.23](/filings/0001288847-26-000023.md) | [0.21](/filings/0001288847-26-000079.md) | [0.04](/filings/0001288847-26-000123.md) |
| Basic EPS | $ per share | [(0.28)](/filings/0001288847-25-000028.md) | [(0.17)](/filings/0001288847-25-000028.md) | [(0.10)](/filings/0001288847-26-000023.md) | [(0.17)](/filings/0001288847-26-000023.md) | [(0.06)](/filings/0001288847-26-000023.md) | [0.15](/filings/0001288847-26-000023.md) | [0.01](/filings/0001288847-26-000079.md) | [0.02](/filings/0001288847-26-000123.md) | [0.23](/filings/0001288847-26-000023.md) | [0.25](/filings/0001288847-26-000023.md) | [0.24](/filings/0001288847-26-000079.md) | [0.04](/filings/0001288847-26-000123.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [128](/filings/0001288847-24-000153.md) | [143](/filings/0001288847-26-000023.md) | [240](/filings/0001288847-25-000119.md) | [176](/filings/0001288847-25-000178.md) | [291](/filings/0001288847-25-000229.md) | [363](/filings/0001288847-26-000123.md) | [370](/filings/0001288847-26-000079.md) | [205](/filings/0001288847-26-000123.md) | [193](/filings/0001288847-25-000229.md) | [232](/filings/0001288847-26-000123.md) | [273](/filings/0001288847-26-000079.md) | [187](/filings/0001288847-26-000123.md) |
| Current assets | $m | [891](/filings/0001288847-23-000156.md) | [924](/filings/0001288847-25-000028.md) | [1,289](/filings/0001288847-24-000061.md) | [1,322](/filings/0001288847-24-000118.md) | [1,204](/filings/0001288847-24-000153.md) | [1,249](/filings/0001288847-26-000023.md) | [1,287](/filings/0001288847-25-000119.md) | [894](/filings/0001288847-25-000178.md) | [949](/filings/0001288847-25-000229.md) | [960](/filings/0001288847-26-000123.md) | [1,005](/filings/0001288847-26-000079.md) | [951](/filings/0001288847-26-000123.md) |
| Total assets | $m | [1,456](/filings/0001288847-23-000156.md) | [1,495](/filings/0001288847-25-000028.md) | [1,871](/filings/0001288847-24-000061.md) | [1,910](/filings/0001288847-24-000118.md) | [2,008](/filings/0001288847-24-000153.md) | [2,051](/filings/0001288847-26-000023.md) | [2,090](/filings/0001288847-25-000119.md) | [1,705](/filings/0001288847-25-000178.md) | [1,768](/filings/0001288847-25-000229.md) | [1,790](/filings/0001288847-26-000123.md) | [1,865](/filings/0001288847-26-000079.md) | [1,830](/filings/0001288847-26-000123.md) |
| Current liabilities | $m | [172](/filings/0001288847-23-000156.md) | [167](/filings/0001288847-25-000028.md) | [184](/filings/0001288847-24-000061.md) | [615](/filings/0001288847-24-000118.md) | [650](/filings/0001288847-24-000153.md) | [642](/filings/0001288847-26-000023.md) | [639](/filings/0001288847-25-000119.md) | [202](/filings/0001288847-25-000178.md) | [206](/filings/0001288847-25-000229.md) | [213](/filings/0001288847-26-000123.md) | [223](/filings/0001288847-26-000079.md) | [229](/filings/0001288847-26-000123.md) |
| Total liabilities | $m | [963](/filings/0001288847-23-000156.md) | [956](/filings/0001288847-25-000028.md) | [1,388](/filings/0001288847-24-000061.md) | [1,385](/filings/0001288847-24-000118.md) | [1,442](/filings/0001288847-24-000153.md) | [1,429](/filings/0001288847-26-000023.md) | [1,426](/filings/0001288847-25-000119.md) | [987](/filings/0001288847-25-000178.md) | [993](/filings/0001288847-25-000229.md) | [1,004](/filings/0001288847-26-000123.md) | [1,036](/filings/0001288847-26-000079.md) | [1,045](/filings/0001288847-26-000123.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [494](/filings/0001288847-23-000156.md) | [538](/filings/0001288847-25-000028.md) | [484](/filings/0001288847-24-000061.md) | [526](/filings/0001288847-24-000118.md) | [566](/filings/0001288847-24-000153.md) | [622](/filings/0001288847-26-000023.md) | [664](/filings/0001288847-25-000119.md) | [717](/filings/0001288847-25-000178.md) | [775](/filings/0001288847-25-000229.md) | [786](/filings/0001288847-26-000123.md) | [830](/filings/0001288847-26-000079.md) | [785](/filings/0001288847-26-000123.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [37.0 d](/filings/0001288847-24-000153.md) | [36.5 d](/filings/0001288847-26-000023.md) | [32.4](/filings/0001288847-25-000119.md) | [19.9 d](/filings/0001288847-25-000178.md) | [41.1 d](/filings/0001288847-25-000229.md) | [49.8 d](/filings/0001288847-26-000023.md) | [48.4](/filings/0001288847-26-000079.md) | [35.1 d](/filings/0001288847-26-000123.md) | [59.2 d](/filings/0001288847-25-000229.md) | [83.6 d](/filings/0001288847-26-000023.md) | [63.9](/filings/0001288847-26-000079.md) | [42.1 d](/filings/0001288847-26-000123.md) |
| Capital expenditure | $m | [3.3 d](/filings/0001288847-24-000153.md) | [11.3 d](/filings/0001288847-26-000023.md) | [12.0](/filings/0001288847-25-000119.md) | [6.8 d](/filings/0001288847-25-000178.md) | [14.4 d](/filings/0001288847-25-000229.md) | [9.3 d](/filings/0001288847-26-000023.md) | [4.7](/filings/0001288847-26-000079.md) | [3.5 d](/filings/0001288847-26-000123.md) | [10.5 d](/filings/0001288847-25-000229.md) | [6.2 d](/filings/0001288847-26-000023.md) | [5.3](/filings/0001288847-26-000079.md) | [17.6 d](/filings/0001288847-26-000123.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001288847-26-000079.md) | [0.0 d](/filings/0001288847-26-000123.md) | not reported | not reported | [10.0](/filings/0001288847-26-000079.md) | [90.0 d](/filings/0001288847-26-000123.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [72.4](/filings/0001288847-25-000028.md) | [72.9](/filings/0001288847-25-000028.md) | [73.5](/filings/0001288847-26-000023.md) | [74.2](/filings/0001288847-26-000023.md) | [74.9](/filings/0001288847-26-000023.md) | [88.6](/filings/0001288847-26-000023.md) | [89.3](/filings/0001288847-26-000079.md) | [88.5](/filings/0001288847-26-000123.md) | [87.3](/filings/0001288847-26-000023.md) | [87.0](/filings/0001288847-26-000023.md) | [86.3](/filings/0001288847-26-000079.md) | [85.5](/filings/0001288847-26-000123.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 74,723,531 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001288847-26-000123.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.